scispace - formally typeset
S

Seung-Mo Hong

Researcher at University of Ulsan

Publications -  383
Citations -  21628

Seung-Mo Hong is an academic researcher from University of Ulsan. The author has contributed to research in topics: Pancreatic cancer & Cancer. The author has an hindex of 53, co-authored 361 publications receiving 17907 citations. Previous affiliations of Seung-Mo Hong include University of Virginia Health System & Johns Hopkins University School of Medicine.

Papers
More filters
Journal ArticleDOI

FGFR1 expression defines clinically distinct subtypes in pancreatic cancer

TL;DR: FGFR1 expression, as estimated by IHC, may be used to define clinically distinct subtypes in pancreatic cancer and may lead to new therapeutic approaches for the FGFR1-positive subtype.
Journal ArticleDOI

A "Clearer" View of Pancreatic Pathology: A Review of Tissue Clearing and Advanced Microscopy Techniques.

TL;DR: The evaluation of 3D histopathology, including pathology of the pancreatic lesions, will provide new insights into lesions that previously were seen, and thought of, only in 2 dimensions.
Journal ArticleDOI

Lymph node size and its association with nodal metastasis in ductal adenocarcinoma of the pancreas

TL;DR: The metastatic nodes are larger than the non-metastatic nodes in PDAC patients, however, the difference in nodal size was too small to be identified with preoperative imaging, and the performance of preoperative radiologic imaging to predict lymph nodal metastasis was not good.
Journal ArticleDOI

Loss of Progesterone Receptor Expression Is an Early Tumorigenesis Event Associated with Tumor Progression and Shorter Survival in Pancreatic Neuroendocrine Tumor Patients

TL;DR: Loss of PR expression was noted in neuroendocrine microadenomas and was observed in the majority of PanNETs, which was associated with increased grade, tumor size, and advanced pT and pN classification and was correlated with decreased patient survival time.
Journal ArticleDOI

In vivo and in vitro propagation of intraductal papillary mucinous neoplasms.

TL;DR: In vivo and in vitro growth of selected IPMNs were attempted based on the hypothesis that IPMNs could be grown in the most severely immunodeficient mice, and one IPMNs, with an associated invasive carcinoma, was successfully established as a cell line.